1190 related articles for article (PubMed ID: 1978757)
1. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.
Malkin D; Li FP; Strong LC; Fraumeni JF; Nelson CE; Kim DH; Kassel J; Gryka MA; Bischoff FZ; Tainsky MA
Science; 1990 Nov; 250(4985):1233-8. PubMed ID: 1978757
[TBL] [Abstract][Full Text] [Related]
2. Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.
Frebourg T; Kassel J; Lam KT; Gryka MA; Barbier N; Andersen TI; Børresen AL; Friend SH
Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6413-7. PubMed ID: 1631137
[TBL] [Abstract][Full Text] [Related]
3. Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma.
Sameshima Y; Tsunematsu Y; Watanabe S; Tsukamoto T; Kawa-ha K; Hirata Y; Mizoguchi H; Sugimura T; Terada M; Yokota J
J Natl Cancer Inst; 1992 May; 84(9):703-7. PubMed ID: 1569604
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma.
Toguchida J; Yamaguchi T; Dayton SH; Beauchamp RL; Herrera GE; Ishizaki K; Yamamuro T; Meyers PA; Little JB; Sasaki MS
N Engl J Med; 1992 May; 326(20):1301-8. PubMed ID: 1565143
[TBL] [Abstract][Full Text] [Related]
5. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.
Srivastava S; Zou ZQ; Pirollo K; Blattner W; Chang EH
Nature; 1990 Dec 20-27; 348(6303):747-9. PubMed ID: 2259385
[TBL] [Abstract][Full Text] [Related]
6. Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome.
Frebourg T; Barbier N; Yan YX; Garber JE; Dreyfus M; Fraumeni J; Li FP; Friend SH
Am J Hum Genet; 1995 Mar; 56(3):608-15. PubMed ID: 7887414
[TBL] [Abstract][Full Text] [Related]
7. p53 Testing for Li-Fraumeni and Li-Fraumeni-like syndromes.
Gonzalez K; Fong C; Buzin C; Sommer SS; Saldivar JS
Curr Protoc Hum Genet; 2008 Apr; Chapter 10():Unit 10.10. PubMed ID: 18428420
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of two novel germ line p53 mutations in the non-LFS/non-LFL breast cancer families in Chinese population.
Cao AY; Jin W; Shi PC; Di GH; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2010 Jan; 119(2):295-303. PubMed ID: 19238535
[TBL] [Abstract][Full Text] [Related]
9. The first documentation of Li-Fraumeni syndrome in Korea.
Bang YJ; Kang SH; Kim TY; Jung CW; Oh SM; Choe KJ; Kim NK
J Korean Med Sci; 1995 Jun; 10(3):205-10. PubMed ID: 8527048
[TBL] [Abstract][Full Text] [Related]
10. Cancer risks from germ line tumor suppressor gene mutations.
Frebourg T; Malkin D; Friend S
Princess Takamatsu Symp; 1991; 22():61-70. PubMed ID: 1844252
[TBL] [Abstract][Full Text] [Related]
11. Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms.
Malkin D; Jolly KW; Barbier N; Look AT; Friend SH; Gebhardt MC; Andersen TI; Børresen AL; Li FP; Garber J
N Engl J Med; 1992 May; 326(20):1309-15. PubMed ID: 1565144
[TBL] [Abstract][Full Text] [Related]
12. Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families.
Manoukian S; Peissel B; Pensotti V; Barile M; Cortesi L; Stacchiotti S; Terenziani M; Barbera F; Pasquini G; Frigerio S; Pierotti MA; Radice P; Della-Torre G
Eur J Cancer; 2007 Feb; 43(3):601-6. PubMed ID: 17224268
[TBL] [Abstract][Full Text] [Related]
13. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR
Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
[TBL] [Abstract][Full Text] [Related]
14. P53 gene mutations in women with breast cancer and a previous history of benign breast disease.
Seth A; Palli D; Mariano JM; Metcalf R; Venanzoni MC; Bianchi S; Kottaridis SD; Papas TS
Eur J Cancer; 1994; 30A(6):808-12. PubMed ID: 7917542
[TBL] [Abstract][Full Text] [Related]
15. Identification of a germ-line mutation in the p53 gene in a patient with an intracranial ependymoma.
Metzger AK; Sheffield VC; Duyk G; Daneshvar L; Edwards MS; Cogen PH
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7825-9. PubMed ID: 1679237
[TBL] [Abstract][Full Text] [Related]
16. Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites.
Rapakko K; Allinen M; Syrjäkoski K; Vahteristo P; Huusko P; Vähäkangas K; Eerola H; Kainu T; Kallioniemi OP; Nevanlinna H; Winqvist R
Br J Cancer; 2001 Jan; 84(1):116-9. PubMed ID: 11139324
[TBL] [Abstract][Full Text] [Related]
17. Incidence of germ-line p53 mutations in patients with gliomas.
Li YJ; Sanson M; Hoang-Xuan K; Delattre JY; Poisson M; Thomas G; Hamelin R
Int J Cancer; 1995 Dec; 64(6):383-7. PubMed ID: 8550239
[TBL] [Abstract][Full Text] [Related]
18. Analysis of p53 tumor suppressor gene in families with multiple glioma patients.
Paunu N; Syrjäkoski K; Sankila R; Simola KO; Helén P; Niemelä M; Matikainen M; Isola J; Haapasalo H
J Neurooncol; 2001 Dec; 55(3):159-65. PubMed ID: 11859970
[TBL] [Abstract][Full Text] [Related]
19. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.
Achatz MI; Olivier M; Le Calvez F; Martel-Planche G; Lopes A; Rossi BM; Ashton-Prolla P; Giugliani R; Palmero EI; Vargas FR; Da Rocha JC; Vettore AL; Hainaut P
Cancer Lett; 2007 Jan; 245(1-2):96-102. PubMed ID: 16494995
[TBL] [Abstract][Full Text] [Related]
20. Germline p53 mutation at codon 133 in a cancer-prone family.
Saeki Y; Tamura K; Yamamoto Y; Hatada T; Furuyama J; Utsunomiya J
J Mol Med (Berl); 1997 Jan; 75(1):50-6. PubMed ID: 9020384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]